ARRY has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Array BioPharma Inc's quarterly cash and cash equivalents increased from Sep. 2013 ($65.05 Mil) to Dec. 2013 ($120.37 Mil) but then declined from Dec. 2013 ($120.37 Mil) to Mar. 2014 ($52.18 Mil).
Array BioPharma Inc's annual cash and cash equivalents increased from Jun. 2011 ($48.10 Mil) to Jun. 2012 ($55.80 Mil) and increased from Jun. 2012 ($55.80 Mil) to Jun. 2013 ($60.74 Mil).
Cash and cash equivalents on banks book.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Array BioPharma Inc Annual Data
Array BioPharma Inc Quarterly Data